Copyright
©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 14, 2005; 11(38): 6072-6073
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6072
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6072
Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?
I. Gil-Bazo, J. García-Foncillas, J.A Díaz González, Department of Oncology, University Clinic, University of Navarra, Pio XII, 36. 31008 Pamplona, Spain
J. A. Páramo, Service of Haematology, University Clinic, University of Navarra, Pio XII, 36. 31008 Pamplona, Spain
J. Cortés, Department of Oncology, Vall d'Hebron, University Hospital, Pg Vall d'sHebron, 119-129, E-08035 Barcelona, Spain
E. Calvo, Institute for Drug Development, Cancer Therapy and Research Center. University of Texas Health Science Center atSan Antonio, 7979 Wurzbach Road, Zeller Building, San Antonio, TX 78229, United States
Author contributions: All authors contributed equally to the work.
Correspondence to: I. Gil-Bazo, MD, PhD, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 241, New York, NY 10021,United States. gilbazoi@mskcc.org
Telephone: +1-21-26392390 Fax: +1-646-4222063
Received: April 30, 2004
Revised: June 6, 2005
Accepted: June 9, 2005
Published online: October 14, 2005
Revised: June 6, 2005
Accepted: June 9, 2005
Published online: October 14, 2005
Core Tip